KR20030096224A - 안정한 주사가능 액체를 위한 조성물 및 방법 - Google Patents

안정한 주사가능 액체를 위한 조성물 및 방법 Download PDF

Info

Publication number
KR20030096224A
KR20030096224A KR10-2003-7004941A KR20037004941A KR20030096224A KR 20030096224 A KR20030096224 A KR 20030096224A KR 20037004941 A KR20037004941 A KR 20037004941A KR 20030096224 A KR20030096224 A KR 20030096224A
Authority
KR
South Korea
Prior art keywords
composition
component
glass
particles
sugar
Prior art date
Application number
KR10-2003-7004941A
Other languages
English (en)
Korean (ko)
Inventor
로저브루스조셉
가르시아드카스트로알카디오
마키제임스
Original Assignee
캠브리지 바이오스테빌리티 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 캠브리지 바이오스테빌리티 리미티드 filed Critical 캠브리지 바이오스테빌리티 리미티드
Publication of KR20030096224A publication Critical patent/KR20030096224A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR10-2003-7004941A 2000-10-13 2000-10-13 안정한 주사가능 액체를 위한 조성물 및 방법 KR20030096224A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020057009395A Division KR100743442B1 (ko) 2005-05-25 2000-10-13 약제적 액체 현탁액

Publications (1)

Publication Number Publication Date
KR20030096224A true KR20030096224A (ko) 2003-12-24

Family

ID=21741883

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7004941A KR20030096224A (ko) 2000-10-13 2000-10-13 안정한 주사가능 액체를 위한 조성물 및 방법

Country Status (12)

Country Link
EP (1) EP1328255A1 (zh)
JP (1) JP2004513093A (zh)
KR (1) KR20030096224A (zh)
CN (1) CN100339066C (zh)
AU (2) AU2001211986B2 (zh)
CA (2) CA2424656C (zh)
ES (1) ES2337252T3 (zh)
MX (1) MXPA03003236A (zh)
NO (1) NO20031706L (zh)
PL (1) PL360052A1 (zh)
PT (1) PT1452171E (zh)
WO (1) WO2002032402A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004037293A1 (ja) * 2002-10-22 2006-02-23 大日本住友製薬株式会社 安定化組成物
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
WO2005099669A1 (en) 2004-04-13 2005-10-27 Cambridge Biostability Limited Liquids containing suspended glass particles
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
JP5301468B2 (ja) * 2008-01-18 2013-09-25 旭化成ファーマ株式会社 安定な医薬組成物
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (en) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension of particles with drug
WO2011007327A2 (en) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension for therapeutic use and device for delivering said suspension
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
EP3124275A4 (en) 2014-03-24 2018-03-14 Seiko Epson Corporation Tape printing device and tape printing system
WO2015145353A1 (en) * 2014-03-27 2015-10-01 Novartis Ag Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (zh) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Also Published As

Publication number Publication date
NO20031706D0 (no) 2003-04-11
CA2424656A1 (en) 2002-04-25
JP2004513093A (ja) 2004-04-30
ES2337252T3 (es) 2010-04-22
CN100339066C (zh) 2007-09-26
EP1328255A1 (en) 2003-07-23
CN1527699A (zh) 2004-09-08
PL360052A1 (en) 2004-09-06
MXPA03003236A (es) 2004-12-03
AU1198601A (en) 2002-04-29
CA2689856C (en) 2013-09-24
CA2424656C (en) 2010-03-23
AU2001211986B2 (en) 2007-04-26
NO20031706L (no) 2003-04-11
CA2689856A1 (en) 2002-04-25
WO2002032402A1 (en) 2002-04-25
PT1452171E (pt) 2010-03-08

Similar Documents

Publication Publication Date Title
US6190701B1 (en) Composition and method for stable injectable liquids
KR20030096224A (ko) 안정한 주사가능 액체를 위한 조성물 및 방법
JP2002504090A (ja) 液体調合物における安定な粒子
AU2001211986A1 (en) Composition and method for stable injectable liquids
EP1750668B1 (en) Liquids containing suspended glass particles
US20110045079A1 (en) Dry powders of cellular material
WO2009114959A1 (zh) 可注射用缓释药物制剂及其制备方法
KR20220008277A (ko) 가스 충전된 미세소포
AU2005203369B2 (en) Pharmaceutical liquid suspensions
KR100743442B1 (ko) 약제적 액체 현탁액
JP4027881B2 (ja) 安定注射液用の組成物および方法
JP4382706B2 (ja) 医薬液体懸濁物
EP1452171B1 (en) Pharmaceutical liquid suspensions
RU2259817C2 (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
KR950005867B1 (ko) 흡입제
KR20010053299A (ko) 미립자 전달 장치 및 사용 방법
NZ538681A (en) A pharmaceutical composition comprising active biological ingredient carried by particles that form a stable suspension in a liquid indefinitely
NZ525026A (en) A two-component composition comprising particles of sugar glass and a biocompatible liquid perfluorocarbon
CN100594937C (zh) 稳定的注射液组合物和方法
WO2015001160A1 (es) Nanopartícula lipídica de polimixina
RU2003113537A (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
AMND Amendment
B601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20051027

Effective date: 20061228